Benjamin Bertrand

Benjamin Bertrand is a seasoned professional with extensive experience in the biotechnology and medical technology sectors. Currently serving as a Board Member at CNRS since 2018, Bertrand co-founded Cardiawave in 2014, where Benjamin has played a pivotal role in the development of a non-invasive medical device for heart valve disease, overseeing significant fundraising efforts. With a strong background in corporate governance, Bertrand has also been a Board Member for the Consortium STOP-AS and held leadership positions in various companies, including Eukarÿs SAS, where Benjamin was CEO and co-founder. Bertrand's expertise encompasses strategic planning, business development, and R&D management, complemented by a robust academic foundation from ESCP Business School in finance and management.